Pharmaceutical Preparations stocks
Every US Pharmaceutical Preparations company with filed annual reports: 6, in the Healthcare sector, with the ratios the screener prints. A name opens the company’s page, where every filed figure carries the filing it was read from and every price the day of its close.
Medians across Pharmaceutical Preparations companies
- Price to earnings
- 5.41x of 1
- Price to book
- 1.13x of 2
- Free cash flow yield
- -15.6% of 1
- Debt to equity
- 0.00 of 1
The companies
| Company | Market cap | P/E | P/B | EV/EBIT | FCF yld | ROIC | D/E | Div yld |
|---|---|---|---|---|---|---|---|---|
| Lakefront Biotherapeutics N.V. LKFT | 1.94B | 5.41x | 0.54x | n/a | -15.6% | n/a | n/a | n/a |
| Faeth Therapeutics, Inc. FTH | 515.6M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Yarrow Bioscience Inc YARW | 175.9M | n/m | n/a | n/a | n/m | n/a | n/a | n/a |
| Korsana Biosciences, Inc. KRSA | 160.7M | n/m | 1.72x | n/a | n/a | n/a | n/a | n/a |
| NOMAD Power Solutions, Inc. NMAD | 48.8M | n/m | n/a | n/a | n/a | n/a | n/a | n/a |
| Rocket One Inc. RKTO | 11.9M | n/m | n/a | n/a | n/a | n/m | 0.0009 | n/a |
Largest published market value first. No ratio orders this list, and a company whose market value is not published is listed last.
Prices as of 2026-10-14. Ratios recomputed from the filings 2026-10-14. Every ratio passes the same applicability gate as the screener and the research page, with the latest filed fiscal year's statements. A list is not a recommendation: see the limits of what this tool can tell you.